KR840001167A - 티아졸리딘알킬렌 피페라진 유도체의 제조방법 - Google Patents

티아졸리딘알킬렌 피페라진 유도체의 제조방법 Download PDF

Info

Publication number
KR840001167A
KR840001167A KR1019820003482A KR820003482A KR840001167A KR 840001167 A KR840001167 A KR 840001167A KR 1019820003482 A KR1019820003482 A KR 1019820003482A KR 820003482 A KR820003482 A KR 820003482A KR 840001167 A KR840001167 A KR 840001167A
Authority
KR
South Korea
Prior art keywords
pyrimidinyl
pharmaceutically useful
thiazolidinedione
piperazinyl
butyl
Prior art date
Application number
KR1019820003482A
Other languages
English (en)
Other versions
KR880001478B1 (ko
Inventor
엘. 팅플. 쥬니어(외 1) 데이비스
Original Assignee
원본미기재
브리스톨 마이어즈 컴페니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 브리스톨 마이어즈 컴페니 filed Critical 원본미기재
Publication of KR840001167A publication Critical patent/KR840001167A/ko
Application granted granted Critical
Publication of KR880001478B1 publication Critical patent/KR880001478B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

내용 없음

Description

티아졸리딘알킬렌 피페라진 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (4)

  1. 하기 구조식(Ⅱ)의 티아졸리디온과 하기 구조식(Ⅲ)의 피페라진을, 충분한 시간동안 약 50℃ 내지 200℃의 온도에서 염기 존재하에 또는 않이, 불활성 반응매체에서 반응시키는, 하기 구조식(Ⅰ)의 화합물의 제조방법.
    R1은 저급알킬 또는 수소, n은 2내지 5의 정수, Z는인 R2치환된 페닐라디칼, R2는 수소, 할로겐, 저급알킬, 저급알콕시 또는 트리플루오로메틸, n은 3,4 또는 5Z는 2-피리미디닐 또는인 R3치환된 2-피리미디닐라디칼, R3은 수소, 시아노 또는 그로 인한 약학적인 수용성 비독성상 부가염, A는 독자적으로 수소, 알칼리 금속염 또는 X-(CH2)n-라디칼인데, X는 반응성 에스테르기의 산 잔여기 n은 2내지 5의 정수, 및/또한 만일 필요하다면 구조식(Ⅰ)의 생성된 화합물은 유리화합물 또는 그외의 염으로 전환될 수 있는 염으로 전환된다.
  2. 제1항에 있어서, 충분한 시간동안 불활성 용매의 환류 상태에서 염기의 존재하에 3-(4-브로모부틸-2,4-티아졸리딘디온과 1-(2-피리미디닐)피페라진을 반응시 켜 3-[4-[4-(2-피리미디닐)-1-피페라지닐]-부틸]-2,4-티아졸리딘디온의 유리된 염기를 생성한후, 상기 유리된 염기를 약학적으로 유용한 산과 약학적으로 유용한 산부가염으로 전환시키는 것으로 이루어진 3-[4-[4-(2-피리미디닐)-1-피페라지닐]-부틸]-2,4-티아졸리딘디온과 그의 약학적으로 유용한 산부가염의 제조방법.
  3. 제1항에 있어서, 충분한 시간동안 불활성용매의 환류상태에서, 염기의 존재하에 3-(4-브로모부틸)-2,4-티아졸리딘 디온과 1-(3｜트리플루오로메틸페닐)-피페라진을 반응시켜 3-[4-[4-[3-(트리플루오로메틸)-페닐]-1-피페라지닐]-부틸]-2,4-티아졸리딘의 유리염기를 생성한뒤 상기 유리된 염기를 약학적으로 유용한산과 약학적으로 유용한 산부가염으로 전환시키는 것으로 이루어진 3-[4-[4-[3-(트리플루오로메틸)-페닐]-1-피페라지닐]-부틸]-2,40티아졸리딘디온과 그의 학적으로 유용한 산부가염의 제조방법.
  4. 실시예 1,2,3과 4-14에 서술된 제조방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR8203482A 1981-08-03 1982-08-03 티아졸리디닐 알킬렌 피페라진 유도체의 제조방법 KR880001478B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US289.352 1981-08-03
US06/289,352 US4367335A (en) 1981-08-03 1981-08-03 Thiazolidinylalkylene piperazine derivatives
US289352 1981-08-03

Publications (2)

Publication Number Publication Date
KR840001167A true KR840001167A (ko) 1984-03-28
KR880001478B1 KR880001478B1 (ko) 1988-08-13

Family

ID=23111164

Family Applications (1)

Application Number Title Priority Date Filing Date
KR8203482A KR880001478B1 (ko) 1981-08-03 1982-08-03 티아졸리디닐 알킬렌 피페라진 유도체의 제조방법

Country Status (28)

Country Link
US (1) US4367335A (ko)
JP (2) JPS5826877A (ko)
KR (1) KR880001478B1 (ko)
AT (1) AT381705B (ko)
AU (1) AU560655B2 (ko)
BE (1) BE894022A (ko)
CA (1) CA1172636A (ko)
CH (1) CH652398A5 (ko)
DE (1) DE3228990A1 (ko)
DK (1) DK162991C (ko)
ES (1) ES8307800A1 (ko)
FI (1) FI76793C (ko)
FR (1) FR2510572B1 (ko)
GB (1) GB2106104B (ko)
GR (1) GR76172B (ko)
HU (1) HU191187B (ko)
IE (1) IE53641B1 (ko)
IL (1) IL66434A0 (ko)
IT (1) IT1149329B (ko)
LU (1) LU84316A1 (ko)
NL (1) NL8203034A (ko)
NZ (1) NZ201159A (ko)
OA (1) OA07172A (ko)
PH (1) PH18220A (ko)
PT (1) PT75366B (ko)
SE (1) SE452320B (ko)
YU (1) YU44074B (ko)
ZA (1) ZA825479B (ko)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456756A (en) * 1981-08-03 1984-06-26 Mead Johnson & Company Spirothiazolidinyl piperazine derivatives
US4452799A (en) * 1981-12-23 1984-06-05 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4620006A (en) * 1982-08-11 1986-10-28 Eastman Kodak Company Acid salts of 1-(cyanoalkyl)-4-guanylpiperazines
US4619930A (en) * 1985-01-16 1986-10-28 Bristol-Myers Company Antipsychotic cyclic imide derivatives of 2-(4-butylpiperazin-1-yl)pyridines, compositions and use
CA1278792C (en) * 1985-05-06 1991-01-08 Joseph P. Yevich Antipsychotic fused-ring pyridinylpiperazine derivatives
US4677104A (en) * 1985-05-06 1987-06-30 Bristol-Myers Company Antipsychotic fused-ring pyridinylpiperazine derivatives
US4675403A (en) * 1985-10-16 1987-06-23 American Home Products Corporation 3-Aminoalkyl derivatives of 5,5-disubstituted hydantoins with psychotropic activity
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5801186A (en) 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
US4880930A (en) * 1987-11-30 1989-11-14 New James S Psychotropic acyclic amide derivatives
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
US5116970A (en) * 1988-02-18 1992-05-26 New James S Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
JPH0415948U (ko) * 1990-05-31 1992-02-10
US5194436A (en) * 1991-01-10 1993-03-16 Hoechst-Roussel Pharmaceuticals Inc. 1-piperazinyl-2-butenes and -2-butynes
US5130315A (en) * 1991-01-10 1992-07-14 Raymond R. Wittekind 1-piperazinyl-2-butenes and -2-butynes
US20040077605A1 (en) * 2001-06-20 2004-04-22 Salvati Mark E. Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
WO2003093236A1 (en) * 2002-05-02 2003-11-13 Euro-Celtique, S.A. 1-(pyrid-2-yl)-piperazine compounds as metabotropic glutamate receptor inhibitor
WO2006013445A2 (en) * 2004-07-28 2006-02-09 Ranbaxy Laboratories Limited Thiazolidinedione derivatives as alpha adrenergic receptor antagonists

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2672460A (en) * 1952-06-24 1954-03-16 American Cyanamid Co Disubstituted piperazines and methods of preparing the same
US2748125A (en) * 1954-04-26 1956-05-29 American Cyanamid Co 1-substituted-4-sulfamylpiperazine and method of preparing the same
NL125835C (ko) * 1960-05-24
FR1435004A (fr) * 1965-02-04 1966-04-15 Sobio Lab Dérivés de thiazolidine-dione-2, 4- et procédé de préparation
US3398151A (en) * 1966-02-01 1968-08-20 Mead Johnson & Co Azaspirodecanediones and azaspiroundecanediones
DE1695410A1 (de) * 1967-04-20 1971-04-08 Merck Patent Gmbh Verfahren zur Herstellung von 1-(Thiazolyl-5-alkyl)-4-(pyridyl-2)-piperazinen
US3635976A (en) * 1967-12-20 1972-01-18 Pennwalt Corp 1 - heterocyclic alkyl-1 2 3 4-tetrahydroquinazolinones and analgesic intermediates thereof
US3822266A (en) * 1968-12-24 1974-07-02 Hoffmann La Roche (3-(1-piperazinyl)-2-hydroxy-propoxy)acetanilides
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione
US3976776A (en) * 1972-12-06 1976-08-24 Mead Johnson & Company Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2263211A1 (de) * 1972-12-23 1974-07-04 Boehringer Sohn Ingelheim Neue arylpiperazine und verfahren zu ihrer herstellung
US3919230A (en) * 1974-02-07 1975-11-11 Smithkline Corp {62 -Naphthylmethyl piperazinyl derivatives
FR2285883A1 (fr) * 1974-09-30 1976-04-23 Cerm Cent Europ Rech Mauvernay Nouveaux composes chimiques a activite bronchospasmolytique et antitussive, et procede pour leur obtention
US3940398A (en) * 1975-01-23 1976-02-24 E. R. Squibb & Sons, Inc. 2-[[4-(Azine or diazine or triazine)-1-piperazinyl]alkyl]-1H-benz[de]isoquinoline-1,3(2H)-diones
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
GB1518559A (en) * 1976-04-12 1978-07-19 Science Union & Cie Naphthyl derivatives processes for their preparation an pharmaceutical compositions containing them
US4078063A (en) * 1976-09-24 1978-03-07 Merck & Co., Inc. Piperazinylpyridines
US4101548A (en) * 1977-02-22 1978-07-18 Bristol-Myers Company 1,2,3-Thiadiazole amides
HU173380B (hu) * 1977-02-25 1979-04-28 Richter Gedeon Vegyeszet Sposob poluchenija novogo proizvodnogo piridil-piperazina i kislo-additivnykh solejj
DE2727469A1 (de) * 1977-06-18 1978-12-21 Hoechst Ag Neue hexahydropyrimidine, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
EP0002978B1 (fr) * 1977-12-29 1982-10-06 Synthelabo Dérivés de thiazolidinedione-2,4, leur préparation et leur application en thérapeutique
FR2418798A1 (fr) * 1978-03-03 1979-09-28 Science Union & Cie Nouvelles piperazines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4182763A (en) * 1978-05-22 1980-01-08 Mead Johnson & Company Buspirone anti-anxiety method
FI791926A (fi) * 1978-06-20 1979-12-21 Synthelabo Fenylpiperazinderivat
US4161595A (en) * 1978-10-02 1979-07-17 Bristol-Myers Company Levulinic acid salt

Also Published As

Publication number Publication date
LU84316A1 (fr) 1983-06-07
JPS5826877A (ja) 1983-02-17
ATA299482A (de) 1986-04-15
US4367335A (en) 1983-01-04
FR2510572A1 (fr) 1983-02-04
DK162991C (da) 1992-06-01
DK162991B (da) 1992-01-06
NL8203034A (nl) 1983-03-01
NZ201159A (en) 1985-10-11
DK343682A (da) 1983-02-04
PT75366B (en) 1985-11-20
ES514264A0 (es) 1983-08-01
ZA825479B (en) 1983-04-27
JPH0371410B2 (ko) 1991-11-13
OA07172A (fr) 1984-04-30
FI76793B (fi) 1988-08-31
AT381705B (de) 1986-11-25
FR2510572B1 (fr) 1986-05-09
SE452320B (sv) 1987-11-23
AU560655B2 (en) 1987-04-16
IT8248909A0 (it) 1982-07-29
FI822667A0 (fi) 1982-07-30
IE53641B1 (en) 1989-01-04
AU8566382A (en) 1983-02-10
YU44074B (en) 1990-02-28
HU191187B (en) 1987-01-28
JPH02270821A (ja) 1990-11-05
FI822667L (fi) 1983-02-04
CA1172636A (en) 1984-08-14
ES8307800A1 (es) 1983-08-01
GB2106104B (en) 1985-05-09
DE3228990A1 (de) 1983-03-03
SE8204550L (sv) 1983-02-04
IT1149329B (it) 1986-12-03
PT75366A (en) 1982-09-01
BE894022A (fr) 1983-02-03
GR76172B (ko) 1984-08-03
JPH0235754B2 (ko) 1990-08-13
PH18220A (en) 1985-04-30
YU158682A (en) 1985-04-30
IL66434A0 (en) 1982-12-31
IE821852L (en) 1983-02-03
FI76793C (fi) 1988-12-12
KR880001478B1 (ko) 1988-08-13
GB2106104A (en) 1983-04-07
CH652398A5 (de) 1985-11-15
SE8204550D0 (sv) 1982-08-02

Similar Documents

Publication Publication Date Title
KR840001167A (ko) 티아졸리딘알킬렌 피페라진 유도체의 제조방법
KR840002827A (ko) 2-[4-[(4,4-디알킬-2,6-피페리딘디온-1-일)부틸]피페라지닐] 피리미딘류의 제조
KR840001952A (ko) N-(4-(3-아미노프로필) 아미노부틸)-2-(ω)-과니디노-지방산-아미도)-2-치환된-에탄아미드 이들의 염 및 이들의 제조방법
KR840002826A (ko) 2-[4-[(4, 4-디알킬-2, 6-피페리디온-1-일)부틸 〕-1-피페라지닐〕피리딘의 제조방법
YU217181A (en) Process for preparing 2-(1,4-benzodioxane-2-ylalkyl)-imidazoles
KR840001166A (ko) 스피로티아졸리딘일 피페라진 유도체 제조방법
CA1132560A (en) Process for inverting the configuration in optically active compounds and new optically active intermediates required therefor and the salts thereof
ATE53034T1 (de) Verfahren zur herstellung von cephemverbindungen.
US3898230A (en) Sydnone imine compounds
HUT44498A (en) Process for production of derivatives of 3-aryl-3-cycloalkyl-piperidine-2,6-dion
KR850004481A (ko) 4, 5-디하이드로-6-[2-[4-(1h-이미다졸-1-일)페닐]-에테닐]-3(2h)-피리다지논류의 제법
KR840001974A (ko) 1-[3-(6-플루오로-1,2-벤즈이속사졸-3-일)프로필]-4-(치환된)-피페라진 및-피레리딘의 제조방법
JPH06184128A (ja) ２−（４−アミノフェニル）ベンゾチアゾール化合物の製法
KR830003475A (ko) 신규의 피리미돈류의 제조방법
US4620002A (en) 2-pyrimidyl alkanesulfonates
JPS5936627B2 (ja) インダゾ−ル誘導体の製法
JPS6210993B2 (ko)
KR840000516A (ko) 아미도벤즈아미드류의 제법
KR870004008A (ko) 아로일티아졸론의 제조방법
EP0805150A3 (en) A method for preparing 1H-1,2,4-triazol-5-YL acetic compounds, and the novel 3-(4-tert-butylphenyl)-1H,2,4-triazol-5-yl acetic acid
KR840006634A (ko) 4-히드록시-2h-1,2-벤조티아진-3-카복사미드-1,1-디옥사이드의 제조방법
KR880006215A (ko) 티아졸 화합물의 제조방법
KR850005408A (ko) 3-인돌아세토 히드록사믹산 유도체의 제조방법
JPS5692279A (en) Thiazolidine derivative
JPS54109969A (en) Novel method of preparing thiazole derivative